QA: UNITED THERAPEUTICS Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001082554_2022_UNITED_THERAPEUTICS_Corp.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001082554, UNITED THERAPEUTICS Corp

  xvar xval
0 AssetsCurrent 2,323,600,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 780,900,000
3 remainder_Assets 2,064,600,000
4 LiabilitiesCurrent 305,400,000
5 LiabilitiesNoncurrent 104,800,000
6 remainder_Liabilities 800,000,000
7 CostOfGoodsAndServicesSold 122,500,000
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 540,100,000
10 remainder_Expenses 585,100,000
11 remainder_Revenues 1,685,500,000
12 remainder_NetIncome 38,000,000
13 remainder_ComprehensiveNetIncome -8,800,000
  yvar yval
0 Assets 5,169,100,000
1 Liabilities 1,210,200,000
2 Expenses 1,247,700,000
3 Revenues 1,685,500,000
4 StockholdersEquity 3,958,900,000
5 NetIncome 475,800,000
6 ComprehensiveNetIncome 471,400,000
7 BaseVar 4,679,650,000
8 EconomicCapitalRatio 2.28

Edgar->Model Mapping

Feature Distribution

Change over Time